Continuous Positive Airway Pressure and Increased Ejection Fraction in Heart Failure and Obstructive Sleep Apnea. Is There a Metabolic Cost or Benefit?**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily reflect the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 49, Issue 4, 2007, Pages 459-460

  Chareonthaitawee, Panithaya ^a   Somers, Virend ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID C 11; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INOTROPIC AGENT;

AEROBIC METABOLISM; AGING; BIOENERGY; BLOOD PRESSURE; CITRIC ACID CYCLE; COMORBIDITY; ECHOCARDIOGRAPHY; EDITORIAL; HEART AFTERLOAD; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE METABOLISM; HEART PRELOAD; HEART RATE; HEART STROKE VOLUME; HUMAN; HYPOXIA; LONG TERM CARE; MORTALITY; OBESITY; OXYGEN CONSUMPTION; POSITIVE END EXPIRATORY PRESSURE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SHORT COURSE THERAPY; SLEEP APNEA SYNDROME; SURVIVAL; SYMPATHETIC FUNCTION; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME;

CONTINUOUS POSITIVE AIRWAY PRESSURE; HEART FAILURE, CONGESTIVE; HUMANS; SLEEP APNEA, OBSTRUCTIVE; STROKE VOLUME;

EID: 33846399741     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.10.041     Document Type: Editorial

References (18)

1. Hunt S.A., Baker D.W., Chin M.H., et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). Circulation 104 (2001) 2996-3007
2. Bradley T.D., and Floras J.S. Sleep apnea and heart failure: part I: obstructive sleep apnea. Circulation 107 (2003) 1671-1678
3. Somers V.K., Gami A.S., and Olson L.J. Treating sleep apnea in heart failure patients: promises but still no prizes. J Am Coll Cardiol 45 (2005) 2012-2014
4. Somers V.K., Mark A.L., and Abboud F.M. Interaction of baroreceptor and chemoreceptor reflex control of sympathetic nerve activity in normal humans. J Clin Invest 87 (1991) 1953-1957
5. Kaneko Y., Floras J.S., Usui K., et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 348 (2003) 1233-1241
6. Mansfield D.R., Gollogly N.C., Kaye D.M., Richardson M., Bergin P., and Naughton M.T. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 169 (2004) 361-366
7. Malone S., Liu P.P., Holloway R., Rutherford R., Xie A., and Bradley T.D. Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure. Lancet 338 (1991) 1480-1484
8. Kim I.S., Izawa H., Sobue T., et al. Prognostic value of mechanical efficiency in ambulatory patients with idiopathic dilated cardiomyopathy in sinus rhythm. J Am Coll Cardiol 39 (2002) 1264-1268
9. Katz A.M. Potential deleterious effects of inotropic agents in the therapy of chronic heart failure. Circulation 73 (1986) III184-III190
10. Eichhorn E.J., Heesch C.M., Barnett J.H., et al. Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 24 (1994) 1310-1320
11. Chatterjee K., Rouleau J.L., and Parmley W.W. Captopril in congestive heart failure: improved left ventricular function with decreased metabolic cost. Am Heart J 104 (1982) 1137-1146
12. Yoshinaga K., Burwash I.G., Leech J.A., et al. The effects of continuous positive airway pressure on myocardial energetics in patients with heart failure and obstructive sleep apnea. J Am Coll Cardiol 49 (2007) 450-458
13. Tamaki N. Other PET tracers. In: Taillefer R., and Tamaki N. (Eds). New Radiotracers in Cardiac Imaging (1999), Appleton and Lange, Stamford, CT 251-257
14. Keogh A.M., Freund J., Baron D.W., and Hickie J.B. Timing of cardiac transplantation in idiopathic dilated cardiomyopathy. Am Cardiol 61 (1988) 418-422
15. Beanlands R.S., Nahmias C., Gordon E., et al. The effects of beta(1)-blockade on oxidative metabolism and the metabolic cost of ventricular work in patients with left ventricular dysfunction: a double-blind, placebo-controlled, positron-emission tomography study. Circulation 102 (2000) 2070-2075
16. Buck A., Wolpers H.G., Hutchins G.D., et al. Effect of carbon-11-acetate recirculation on estimates of myocardial oxygen consumption by PET. J Nucl Med 32 (1991) 1950-1957
17. Sun K.T., Yeatman L.A., Buxton D.B., et al. Simultaneous measurement of myocardial oxygen consumption and blood flow using [1-carbon-11] acetate. J Nucl Med 39 (1998) 272-280
18. Gropler R.J. Noninvasive measurements of myocardial oxygen consumption-can we do better?. J Am Coll Cardiol 41 (2003) 468-470